A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetic Macular Edema

In brief

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS 01 as compared to Vehicle in participants with Diabetic Macular Edema (DME).

Key facts

Study ID
NCT06172257
Run by
Oculis
People needed
401
Starts
2024-03-15
Expected to finish
2026-04-02
Last updated by the study team
2026-05-01

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.